Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (41-50 of 250) with videos related to

Pageof 25
Sort By:
Critical Reviews in Oncology/Hematology|August 11, 2020
Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic reviewEline Janssens, Jan P van Meerbeeck, Kevin Lamote
Annals of Translational Medicine|December 5, 2017
Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussionJo Raskin, Annelies Janssens, Jan P Van Meerbeeck
Journal of Thoracic Disease|May 1, 2018
International trends in the clinical epidemiology of malignant pleural mesotheliomaRonald A M Damhuis, Jan P van Meerbeeck
The New England Journal of Medicine|January 11, 2013
Fibulin-3 as a biomarker for pleural mesotheliomaKevin Lamote, Paul Baas, Jan P van Meerbeeck
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 1, 1996
Early bronchopleural fistula after lung resectionP E Van Schil, J P Van Meerbeeck
Journal of Advanced Research|August 11, 2015
Mesothelioma treatment: Are we on target? A reviewBirgitta I Hiddinga, Christian Rolfo, Jan P van Meerbeeck
Current Opinion in Oncology|February 25, 2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancerSofie De Craene, Veerle Surmont, Jan P van Meerbeeck
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 23, 2010
The emerging role for combined endosonography with fine needle aspiration in lung cancer staging: is the scope the right one?Kurt G Tournoy, Jan P van Meerbeeck, Frank Vermassen
Expert Review of Anticancer Therapy|February 19, 2008
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Jan P Van Meerbeeck, Rebecca De Pauw, Kurt Tournoy
Panminerva Medica|May 17, 2013
Management of malignant pleural mesothelioma: have we made any progress?B I Hiddinga, V F Surmont, J P Van Meerbeeck
Pageof 25

Showing results (41-50 of 250) with videos related to

Sort By:
Pageof 25
Critical Reviews in Oncology/Hematology|August 11, 2020
Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic reviewEline Janssens, Jan P van Meerbeeck, Kevin Lamote
Annals of Translational Medicine|December 5, 2017
Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussionJo Raskin, Annelies Janssens, Jan P Van Meerbeeck
Journal of Thoracic Disease|May 1, 2018
International trends in the clinical epidemiology of malignant pleural mesotheliomaRonald A M Damhuis, Jan P van Meerbeeck
The New England Journal of Medicine|January 11, 2013
Fibulin-3 as a biomarker for pleural mesotheliomaKevin Lamote, Paul Baas, Jan P van Meerbeeck
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 1, 1996
Early bronchopleural fistula after lung resectionP E Van Schil, J P Van Meerbeeck
Journal of Advanced Research|August 11, 2015
Mesothelioma treatment: Are we on target? A reviewBirgitta I Hiddinga, Christian Rolfo, Jan P van Meerbeeck
Current Opinion in Oncology|February 25, 2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancerSofie De Craene, Veerle Surmont, Jan P van Meerbeeck
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 23, 2010
The emerging role for combined endosonography with fine needle aspiration in lung cancer staging: is the scope the right one?Kurt G Tournoy, Jan P van Meerbeeck, Frank Vermassen
Expert Review of Anticancer Therapy|February 19, 2008
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Jan P Van Meerbeeck, Rebecca De Pauw, Kurt Tournoy
Panminerva Medica|May 17, 2013
Management of malignant pleural mesothelioma: have we made any progress?B I Hiddinga, V F Surmont, J P Van Meerbeeck
Pageof 25